Skip to main content
. Author manuscript; available in PMC: 2022 Mar 21.
Published in final edited form as: Br J Haematol. 2020 Nov 18;192(3):542–550. doi: 10.1111/bjh.17225

Figure 2.

Figure 2.

Kaplan-Meier progression-free survival (PFS) curves starting at the 12-month mark in Waldenström macroglobulinemia patients. Learning cohort: (A) PFS, (B) PFS according to attaining partial response (PR) at 12 months or not, and (C) PFS according to attaining very good partial response (VGPR) at 12 months or not. Validation cohort: (D) PFS, (E) PFS according to attaining PR at 12 months or not, (F) PFS according to attaining VGPR at 12 months or not.